Atossa Therapeutics, Inc.

ATOS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
CORRESP Apr 27, 2021
UPLOAD Apr 26, 2021
S-3 Apr 21, 2021 FORM S-3
DEF 14A Apr 15, 2021 FORM DEF 14A
PRE 14A Apr 5, 2021 FORM PRE 14A
S-8 Mar 31, 2021 FORM S-8
10-K Mar 31, 2021 FORM 10-K
8-K Mar 31, 2021 FORM 8-K
424B5 Mar 23, 2021 FORM 424B5
8-K Mar 23, 2021 FORM 8-K
S-3MEF Mar 22, 2021 FORM S-3MEF
8-K Mar 22, 2021 FORM 8-K
424B2 Feb 4, 2021 FORM 424B2
EFFECT Jan 29, 2021
CORRESP Jan 28, 2021
UPLOAD Jan 28, 2021
S-3 Jan 22, 2021 FORM S-3
SC 13G Jan 15, 2021 SCHEDULE 13G
SC 13G Jan 15, 2021 SC 13G
SC 13G/A Jan 15, 2021 SC 13G/A
SC 13G Jan 14, 2021 ATOSSA THERAPEUTICS, INC.
424B3 Jan 8, 2021 FORM 424B3
8-K Jan 8, 2021 FORM 8-K
SC 13G Dec 28, 2020 SCHEDULE 13G
424B5 Dec 21, 2020 FORM 424B5
← Newer Page 9 of 26 · 641 filings Older →